Related Experiment Videos
Allergic bronchopulmonary aspergillosis
J L Oak1, D R Yavgal, R Chakore
1Department of Medicine, Seth GS Medical College & KEM Hospital, Parel, Mumbai.
Journal of Postgraduate Medicine
|April 1, 1996
Summary
Allergic bronchopulmonary aspergillosis (ABPA) in a 38-year-old male showed significant improvement with prednisolone treatment. This case highlights effective corticosteroid therapy for ABPA.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Infectious Diseases
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory lung disease caused by an immune response to Aspergillus fumigatus.
- ABPA commonly affects individuals with asthma or cystic fibrosis, presenting with diverse respiratory symptoms.
Observation:
- A 38-year-old male patient presented with symptoms indicative of ABPA.
- Diagnostic workup confirmed the presence of allergic bronchopulmonary aspergillosis.
Findings:
- The patient received treatment with prednisolone, a corticosteroid medication.
- Remarkable clinical improvement was observed following prednisolone therapy, indicating treatment efficacy.
Implications:
- This case underscores the effectiveness of systemic corticosteroids like prednisolone in managing ABPA.
- Early diagnosis and appropriate treatment are crucial for favorable outcomes in ABPA patients.
- Further research into optimal treatment durations and steroid-sparing agents for ABPA is warranted.